DUNHAM TRUST Co’s Calidi Biotherapeutics CLDI Stock Holding History
Bought
Maintained
Sold
Other funds holding CLDI
DUNHAM TRUST Co's CLDI Position: Q3 2026 in Review
DUNHAM TRUST Co held its Calidi Biotherapeutics (CLDI) position steady in Q3 2026 at 3,180 shares worth $3.4K. The position accounts for ﹤0.01% of the portfolio, ranked #273.
DUNHAM TRUST Co first reported a position in CLDI in Q4 2025 and has held it in 3 quarters since. The position peaked at $59.5K in Q4 2025. 20 funds tracked by Wall St. Rank hold CLDI as of Q3 2026.
- DUNHAM TRUST Co held 3,180 shares of Calidi Biotherapeutics worth $3.4K as of Q3 2026.
- DUNHAM TRUST Co left its Calidi Biotherapeutics share count unchanged in Q3 2026.
- Calidi Biotherapeutics made up ﹤0.01% of DUNHAM TRUST Co's portfolio in Q3 2026, its #273 holding.
- DUNHAM TRUST Co first reported a position in Calidi Biotherapeutics in Q4 2025 and has held it in 3 quarters since.
- DUNHAM TRUST Co's Calidi Biotherapeutics position peaked at $59.5K in Q4 2025.
- 20 funds tracked by Wall St. Rank held Calidi Biotherapeutics as of Q3 2026.
Based on DUNHAM TRUST Co's 13F filing for Q3 2026, filed 16 Nov 2026.